Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes

Diabetologia

Volumn 56, Issue 12, 2013, Pages 2733-2742

  Mohammedi, Kamel ^a,b   Patente, Thiago A ^a,c   Bellili Muñoz, Naïma ^a   Driss, Fathi ^b,d   Monteiro, Maria Beatriz ^c   Roussel, Ronan ^b,e,f   Pavin, Elizabeth J ^g   Seta, Nathalie ^b,e   Fumeron, Frédéric ^a,e   Azevedo, Mirela J ^h   Canani, Luis H ^h   Hadjadj, Samy ^a,i,j   Marre, Michel ^a,b,e   Corrêa Giannella, Maria Lúcia ^c   Velho, Gilberto ^a  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

^g UNIVERSITY OF CAMPINAS   (Brazil)

^h HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

ⁱ POITIERS UNIVERSITY HOSPITAL   (France)

^j UNIVERSITÉ DE POITIERS   (France)

more..

Author keywords

Catalase; Diabetic nephropathy; End stage renal disease; Oxidative stress

Indexed keywords

CATALASE;

ADULT; ARTICLE; CAT GENE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BELGIUM; BRAZIL; CATALASE; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; GENE FREQUENCY; GENETIC VARIATION; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84887940875     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3057-z     Document Type: Article

References (43)

1. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH (2005) Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 67:1684-1691
2. Orchard TJ, Secrest AM, Miller RG, Costacou T (2010) In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 53:2312-2319
3. Pirart J, Lauvaux JP, Rey W (1978) Blood sugar and diabetic complications. N Engl J Med 298:1149
4. The Diabetes Control and Complications Trial Research Group (1997) Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46:1829-1839
5. Marre M, Jeunemaitre X, Gallois Y et al (1997) Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99:1585-1595
6. Al-Kateb H, Boright AP, Mirea L et al (2008) Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes 57:218-228
7. Mohammedi K, Maimaitiming S, Emery N et al (2011) Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol Genet Metab 104:654-660
8. Du XL, Edelstein D, Rossetti L et al (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226
9. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
10. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625
11. Niedowicz DM, Daleke DL (2005) The role of oxidative stress in diabetic complications. Cell Biochem Biophys 43:289-330
12. Ceriello A, Morocutti A, Mercuri F et al (2000) Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49:2170-2177
13. Coughlan MT, Mibus AL, Forbes JM (2008) Oxidative stress and advanced glycation in diabetic nephropathy. Ann N Y Acad Sci 1126:190-193
14. Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446-1454
15. Mates JM, Perez-Gomez C, Nunez de Castro I (1999) Antioxidant enzymes and human diseases. Clin Biochem 32:595-603
16. Deisseroth A, Dounce AL (1970) Catalase: physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev 50:319-375
17. Brezniceanu ML, Liu F, Wei CC et al (2007) Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 71:912-923
18. Brezniceanu ML, Liu F, Wei CC et al (2008) Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 57:451-459
19. Hwang I, Lee J, Huh JY et al (2012) Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 61:728-738
20. Shi Y, Lo CS, Chenier I et al (2013) Overexpression of catalase prevents hypertension and tubulo-fibrosis and normalization of renal angiotensin- converting enzyme-2 expression in Akita mice. Am J Physiol Renal Physiol 304:F1335-F1346
21. Forsberg L, Lyrenas L, de Faire U, Morgenstern R (2001) A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 30:500-505
22. Hadjadj S, Belloum R, Bouhanick B et al (2001) Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. J Am Soc Nephrol 12:541-549
23. Vieira SM, Monteiro MB, Marques T et al (2011) Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus. BMC Med Genet 12:129
24. Pimenta JR, Zuccherato LW, Debes AA et al (2006) Color and genomic ancestry in Brazilians: a study with forensic microsatellites. Hum Hered 62:190-195
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470
26. Kohner EM (1991) The lesions and natural history of diabetic retinopathy. In: Pickup J, Williams G (eds) Textbook of diabetes. Blackwell, Oxford, pp 575-588
27. Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769
28. Cao C, Leng Y, Kufe D (2003) Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J Biol Chem 278:29667-29675
29. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG (2003) The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 52:846-851
30. Heistad DD (2006) Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol 26:689-695
31. Montezano AC, Touyz RM (2012) Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies. Ann Med 44(Suppl 1):S2-S16
32. Devi TS, Hosoya K, Terasaki T, Singh LP (2013) Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy. Exp Cell Res 319:1001-1012
33. de Cavanagh EM, Inserra F, Ferder L, Fraga CG (2000) Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am J Physiol Regul Integr Comp Physiol 278:R572-R577
34. Lazaro A, Gallego-Delgado J, Justo P et al (2005) Long-term blood pressure control prevents oxidative renal injury. Antioxid Redox Signal 7:1285-1293
35. Portero-Otin M, Pamplona R, Boada J et al (2008) Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats. Biochem Biophys Res Commun 368:528-535
36. Chappell MC (2012) Nonclassical renin-angiotensin system and renal function. Compr Physiol 2:2733-2752
37. Ewens KG, George RA, Sharma K, Ziyadeh FN, Spielman RS (2005) Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 54:3305-3318
38. Kottgen A, Pattaro C, Boger CA et al (2010) New loci associated with kidney function and chronic kidney disease. Nat Genet 42:376-384
39. Sandholm N, Salem RM, McKnight AJ et al (2012) New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet 8:e1002921
40. Perianayagam MC, Liangos O, Kolyada AY et al (2007) NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 18:255-263
41. Crawford A, Fassett RG, Coombes JS et al (2011) Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease. Nephrol Dial Transplant 26:2806-2813
42. Goth L, Nagy T, Kosa Z et al (2012) Effects of rs769217 and rs1001179 polymorphisms of catalase gene on blood catalase, carbohydrate and lipid biomarkers in diabetes mellitus. Free Radic Res 46:1249-1257
43. Godin N, Liu F, Lau GJ et al (2010) Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Kidney Int 77:1086-1097